CHIPPING CAMPDEN SURGERY
BACK ENDS, CHIPPING CAMPDEN
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 53 | 56 | 94.6% | |
| CKD 4 | 2008 | 61 | 68 | 89.7% | |
| CKD 5 | 2009 | 7 | 8 | 87.5% | |
| CKD 5 | 2010 | 8 | 9 | 88.9% | |
| CKD 5 | 2011 | 6 | 7 | 85.7% | |
| CKD 5 | 2012 | 15 | 16 | 93.8% | |
| CKD 5 | 2013 | 14 | 15 | 93.3% | |
| CKD003 | 2014 | 14 | 15 | 93.3% | |
| CKD003 | 2015 | 17 | 18 | 94.4% | |
| NM84 | 2018 | 16 | 21 | 76.2% | |
| NM84 | 2020 | 17 | 20 | 85.0% | |
| NM84 | 2022 | 12 | 14 | 85.7% |
